Clinical Trial Update: Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial compares paclitaxel versus irinotecan in patients with recurrent or metastatic gastric cancer who progressed after first-line therapy. The statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Korean Cancer Study Group | Conditions: Gastric Cancer | Phase 3 | Status: UNKNOWN